Logo image of MNLX.CA

MINILUXE HOLDING CORP (MNLX.CA) Stock Fundamental Analysis

TSX-V:MNLX - TSX Venture Exchange - CA60365X1006 - Common Stock - Currency: CAD

0.6  0 (0%)

Fundamental Rating

1

MNLX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 3 industry peers in the Diversified Consumer Services industry. MNLX has a bad profitability rating. Also its financial health evaluation is rather negative. MNLX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MNLX had negative earnings in the past year.
MNLX.CA Yearly Net Income VS EBIT VS OCF VS FCFMNLX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -68.76%, MNLX is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -68.76%
ROE N/A
ROIC N/A
ROA(3y)-89.67%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNLX.CA Yearly ROA, ROE, ROICMNLX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 41.70%, MNLX is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of MNLX has grown nicely.
MNLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.74%
GM growth 5YN/A
MNLX.CA Yearly Profit, Operating, Gross MarginsMNLX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300

0

2. Health

2.1 Basic Checks

MNLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MNLX has been increased compared to 1 year ago.
Compared to 1 year ago, MNLX has a worse debt to assets ratio.
MNLX.CA Yearly Shares OutstandingMNLX.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M 50M
MNLX.CA Yearly Total Debt VS Total AssetsMNLX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

MNLX has an Altman-Z score of 0.69. This is a bad value and indicates that MNLX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.69, MNLX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACCN/A
WACC10.44%
MNLX.CA Yearly LT Debt VS Equity VS FCFMNLX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.42 indicates that MNLX may have some problems paying its short term obligations.
The Current ratio of MNLX (0.42) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.32 indicates that MNLX may have some problems paying its short term obligations.
MNLX's Quick ratio of 0.32 is on the low side compared to the rest of the industry. MNLX is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.32
MNLX.CA Yearly Current Assets VS Current LiabilitesMNLX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

3

3. Growth

3.1 Past

MNLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.91%, which is quite good.
MNLX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.36%.
MNLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.27% yearly.
EPS 1Y (TTM)16.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)14.36%
Revenue growth 3Y32.27%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MNLX.CA Yearly Revenue VS EstimatesMNLX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 5M 10M 15M 20M
MNLX.CA Yearly EPS VS EstimatesMNLX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

MNLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MNLX.CA Price Earnings VS Forward Price EarningsMNLX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MNLX.CA Per share dataMNLX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MNLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MINILUXE HOLDING CORP

TSX-V:MNLX (3/4/2025, 7:00:00 PM)

0.6

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-28 2024-11-28
Earnings (Next)04-28 2025-04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.73%
Ins Owner ChangeN/A
Market Cap40.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.54
BVpS-0.12
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.7%
FCFM N/A
ROA(3y)-89.67%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.74%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.87
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.32
Altman-Z 0.69
F-ScoreN/A
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)48.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.45%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.36%
Revenue growth 3Y32.27%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.14%
OCF growth 3YN/A
OCF growth 5YN/A